Millipore Sigma Vibrant Logo

AGX824 SARS-CoV-2 Spike (aa 251-660) Recombinant Antigen, 518

COVID-19 Spike (aa 251-660) Recombinant Antigen expressed in E. coli, Cat. No. AGX824 is for use in ELISA and Lateral Flow Assay.

AGX824
1 mg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information
      Description
      Catalogue NumberAGX824
      DescriptionSARS-CoV-2 Spike (aa 251-660) Recombinant Antigen, 518
      Alternate Names
      • COVID-19
      • 2019-nCoV
      Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 spike antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
      References
      Product Information
      FormatPurified
      PresentationPurified protein in 20mM Citrate buffer without perservatives, pH 9.5.
      Quality LevelMQ100
      Applications
      ApplicationCOVID-19 Spike (aa 251-660) Recombinant Antigen expressed in E. coli, Cat. No. AGX824 is for use in ELISA and Lateral Flow Assay.
      Key Applications
      • ELISA
      • Immunodiffusion
      Application NotesAlternative antigen recommendations are AGX821, AGX822, or AGX823
      Biological Information
      Immunogenfragment
      CloneN/A
      ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
      HostE. coli
      Purification MethodColumn Purification
      UniProt Number
      Molecular Weight45 kDa
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size1 mg
      Transport Information
      Supplemental Information
      Specifications